• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Recalls

Dexcom updates CGM receiver recall that led to serious adverse events

July 18, 2025 By Sean Whooley

Dexcom One+ CGM phone and receiver (1)

Dexcom (Nasdaq:DXCM) has issued an update related to a recall for its continuous glucose monitor (CGM) components. Last month, the FDA disclosed Dexcom’s recalls related to its Dexcom One and One+ offerings and the G6 and G7 CGMs. The One and One+ systems, which are mainly the company’s commercial CGM offering outside the U.S., feature the established G6 and G7 sensors […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Patient Monitoring, Recalls, Regulatory/Compliance, Technology Tagged With: Dexcom, FDA

BD issues voluntary recall on certain Alaris infusion pump modules

July 16, 2025 By Sean Whooley

BD Alaris Infusion System updated FDA clearance

BD (NYSE:BDX) announced a voluntary recall related to certain Alaris and Alaris infusion pump modules. Affected Alaris products may have been serviced with previously recalled bezel kit assemblies. BD in 2019 recalled those kit assemblies manufactured between April 2011 and June 2017. They should not be used for service with the Alaris and Alaris Pump […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance, Technology Tagged With: BD

Zyno recalls certain infusion pumps due to software issue

June 18, 2025 By Sean Whooley

Zyno Medical infusion pump recall screenshot

The FDA classified a recall of certain Zyno Medical infusion pump systems as the most serious kind as a result of a software issue. This recall involves removing certain devices from use or sale. As the most serious type of recall, it means the device may cause serious injury or death if its use continues. […]

Filed Under: Drug-Device Combinations, Featured, Recalls, Technology Tagged With: Zyno Medical

Dexcom has a Class I CGM receiver recall

June 17, 2025 By Sean Whooley

Dexcom One+ CGM phone and receiver (1)

The FDA’s recall database today posted notices related to a Class I recall for continuous glucose monitor (CGM) components made by Dexcom (Nasdaq:DXCM). Dexcom’s recalls relate to its Dexcom One and One+ offerings and the G6 and G7 CGMs. The One and One+ systems, which are mainly the company’s commercial CGM offering outside the U.S., feature […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Patient Monitoring, Recalls, Regulatory/Compliance, Technology Tagged With: Dexcom, FDA

Baxter issues serious correction for large-volume infusion pump

June 9, 2025 By Sean Whooley

Baxter Novum IQ Syringe Pump

The FDA has warned of a serious potential issue with Novum IQ large-volume infusion pumps made by Baxter (NYSE:BAX). Baxter’s recall of the system involves updating instructions for use. It does not require removal from use or sale. However, the FDA identified it as the most serious type of recall, carrying the risk of injury […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance, Technology Tagged With: Baxter, FDA

Smiths Medical warns on trio of infusion pump issues

June 4, 2025 By Sean Whooley

Smiths Medical

The FDA issued three notices identifying warnings sent out by ICU Medical‘s Smiths Medical unit related to infusion pump problems. Smiths Medical warned of issues with some of its CADD-Solis and CADD-Solis VIP ambulatory infusion pumps. The CADD-Solis pump offers utility in hospital or outpatient settings, delivering pain therapies. CADD-Solis VIP pumps are intended for […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance Tagged With: FDA, ICU Medical, Smiths Medical

Baxter warns on certain infusion pumps with missing screws

March 5, 2025 By Sean Whooley

Baxter Sigma Spectrum Infusion System and Spectrum IQ Infusion System (1)

The FDA today issued a notice warning of a potential high-risk issue with certain Baxter (NYSE:BAX) Spectrum infusion pump systems. This communication came as part of the FDA’s pilot to enhance its medical device recall program. It follows a letter from Baxter recommending that customers remove certain Spectrum pumps from where they are used or sold. […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Recalls Tagged With: Baxter, Baxter International, FDA

Medtronic warns on air pressure issue with certain MiniMed insulin pumps in Europe

February 14, 2025 By Sean Whooley

MiniMed 780G with Guardian 4 Medtronic

Medtronic (NYSE:MDT) issued an urgent field safety notice in Europe related to multiple versions of its MiniMed insulin pump systems. The medtech giant’s notice includes models of the MiniMed 640G, 670G, 720G, 740G, 770G and 780G insulin pumps. During quality testing performed by Medtronic, the company said it recently found that changes in air pressure […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Recalls, Regulatory/Compliance, Technology Tagged With: Medtronic

Dexcom warns of missed G6 receiver alerts in Europe

February 10, 2025 By Sean Whooley

Dexcom urgent field safety notice G6 receiver

Dexcom (Nasdaq:DXCM) recently issued an urgent field safety notice in Europe warning of a potential issue with certain G6 receivers. G6 continuous glucose monitor (CGM) receivers deliver glucose readings and alerts. However, certain devices may experience an issue in which alarms/alerts fail to function as designed. In rare instances, the alarm/alert may be missed or […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Recalls, Regulatory/Compliance, Technology Tagged With: Dexcom

Cardinal Health recalls certain insulin syringe component packs

December 5, 2024 By Sean Whooley

Cardinal Health Monoject 100 mL luer lock insulin syringe recall

The FDA deemed a recall of Cardinal Health (NYSE:CAH) insulin syringe luer lock packs as type I, the most serious kind of recall. This recall relates to the company’s Monoject U-100 mL insulin syringe luer lock with tip cap soft pack (extended conical tip). The device is used to administer insulin under the skin (subcutaneous) or […]

Filed Under: Diabetes, Drug-Device Combinations, Food & Drug Administration (FDA), Recalls Tagged With: Cardinal Health, FDA

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Interim pages omitted …
  • Page 12
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS